It is hypothesized that FABP4 concentrations may serve as a valuable circulating Biomarker for certain metabolic disorders, including obesity, metabolic syndrome, and type 2 diabetes. The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.